Analysis and modification of approaches to intensive care of critical complications of nephrotic syndrome in children

According to the World Association of Pediatric Nephrologists, the incidence of primary nephrotic syndrome (NS) is 3-12 cases per 100,000 children and tends to increase. The number of patients with a progressive course of the disease is growing every year, and nephrotic syndrome with severe proteinuria, hypoalbuminemia, anasarca occurs in 2-4 per 10,000 children under the age of 16.

BACKGROUND: analysis and modification of approaches to intensive care of critical complications of nephrotic syndrome in children.

PATIENTS AND METHODS: A clinical and laboratory examination of 120 sick children suffering from NS was carried out. In accordance with international standards, the patients were divided into SRNS and SRNS in accordance with the response to the standard course of steroid therapy (prednisone 60 mg/m²/day).

RESULTS: Based on the results of our study and on the basis of a correlation analysis of the indicators of renal sodium retention with parameters reflecting volemic disorders in generalized edema in children with HCNS and SRNS, it was possible to establish clinical and functional criteria for the nature of the causes of edema (Figure 6). At the same time, mainly this group (in 11 cases – 45%) with refractory edema consisted mainly of children with HCV, in whom critical hypoalbuminemia (less than 15 g / l in plasma), critical renal sodium retention (FENa <0.2%) and intravascular reduction in fluid volume (hypovolemia: decrease average indices of the index of the area of the NIP, volumetric blood flow through the inferior vena cava and renal veins against the background of a decrease in the diastolic index of the left ventricle, shock and cardiac indices).

CONCLUSION: in children with nephrotic edema of normovolemic and hypervolemic variants with steroid-resistant NS occurring with arterial hypertension, oliguria and a decrease in the glomerular filtration index of the kidneys, high efficacy of furosemide at a dose of 3-5 mg/ kg of body weight and the absence of a reliable effect of albumin and colloidal solutions were noted when relieving generalized edema, which excludes the use of the latter in our recommendations on the revision of approaches to intensive care of NS in children.

1. Brad H. Rovin, Sharon G. Adler, Jonathan Barratt et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Translated into Russian by Elena Zakharova. Nephrologу and Dialуsis 2022; 24(1):21–51. doi: 10.28996/2618-9801-2022-1-21-51

2. Savenkova ND, Batrakov DD. Hereditary nephrotic syndrome in children: features of clinical phenotype and genotype, pathogenesis, renal prognosis of isolated and syndromic forms. Russian Bulletin of Perinatology and Pediatrics 2023;68(2):13–21. (In Russ.) https://doi.org/10.21508/1027-4065-2023-68-2-13-21

3. Nosov VP, Solovyanova EN, Koroleva LYu. Nephrotic syndrome as a risk factor for thrombotic and thromboembolic complications. Nephrology and dialysis 2021;23(3):366–378. (In Russ.) doi: 10.28996/2618-9801-2021-3-366-378

4. Van de Walle JG, Donckerwolcke RA, Greidanus TB et al. Renal sodium handling in children with nephrotic relapse: relation to hypovolaemic symptoms. Nephrol Dial Transplant 1996 Nov;11(11):2202–2208. doi: 10.1093/oxfordjournals.ndt.a027137

5. Haws RM, Baum M. Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics 1993 Jun; 91(6):1142–1146

6. Razdolkina TI, Shkurin PA. Clinical case of diagnosis and treatment of steroid-dependent nephrotic syndrome in a child [Electronic resource]. Ogarev-online. 2022; (12). (In Russ.) Access mode: https://journal.mrsu.ru/arts/klinicheskij-sluchajdiagnostiki-i-lecheniya-steroidzavisimogo-nefroticheskogosindroma-u-rebenka

7. Shinkawa K, Yoshida S, Seki T, Yanagita M, Kawakami K. Risk factors of venous thromboembolism in patients with nephrotic syndrome: a retrospective cohort study. Nephrol Dial Transplant 2020;1–8. doi:10.1093/ndt/gfaa134 (https://doi.org/10.1093/ndt/gfaa134)

8. Downie E, Diep J, Sungala N, Wong J. IgM nephropathy complicated by cerebral venous sinus thrombosis: a case study. BMC Nephrol 2020; 21(1):390. doi:10.1186/s12882-020-02048-5

9. Schijvens AM. Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome. Pediatr Nephrol 2019; 34 (3):389–403

10. Alizada U, Sauleau EA, Krummel T et al. The REIN registry. Effect of emergency start and central venous catheter on outcomes in incident hemodialysis patients: a prospective observational cohort. J Nephrol 2022;35(3):977–988. https://doi.org/10.1007/s40620-021-01188-7

11. Capolongo G, Capasso G, Viggiano D. A Shared Nephroprotective Mechanism for Renin-Angiotensin-System Inhibitors, Sodium-Glucose Co-Transporter 2 Inhibitors, and Vasopressin Receptor Antagonists: Immunology Meets Hemodynamics. Int J Mol Sci 2022;23(7):3915. https://doi.org/10.3390/ijms23073915

12. Nalcacioglu H, Ozkaya O, Baysal K, Kafali HC, Avci B, Tekcan D et al. The role of bioelectrical impedance analysis, NTProBNP and inferior vena cava sonography in the assessment of body fluid volume in children with nephrotic syndrome. Nefrologia Jan-Feb 2018;38(1):48–56. doi: 10.1016/j.nefro.2017.04.003